Member in focus Peter Piot receives the 2026 Virchow Prize

50 years after the discovery of the Ebola virus, the Belgian-British physician and microbiologist Peter Piot, together with the Congolese microbiologist Jean-Jacques Muyembé-Tamfum, is to be awarded the 2026 Virchow Prize. Piot is regarded as a co-discoverer of the Ebola virus; Muyembe laid the groundwork for this in 1976 through his field investigations as a doctor in Zaire, now the Democratic Republic of the Congo, whose Institut National pour la Recherche Biomédicale he now heads as Director-General in Kinshasa. With this award, the Virchow Foundation honours the achievements of the two physicians and scientists in the discovery and understanding of infectious diseases, as well as their contributions to multilateral cooperation and governance in combating them. The prize is endowed with 500,000 euros. Piot has been a member of the Leopoldina since 2018 and today teaches as Professor of Global Health at the London School of Hygiene and Tropical Medicine.

Peter Piot’s research focuses primarily on the clinical, microbiological, epidemiological and health-policy aspects of infectious diseases, particularly sexually transmitted infections. In 1976, Piot, together with colleagues in Belgium, succeeded in isolating the highly contagious and often fatal Ebola virus. This was done using samples that the physician Jean-Jacques Muyembe, who is now also being honoured, had collected during his investigations into the first documented outbreak of haemorrhagic fever in Zaire and had also sent to laboratories in the USA and Belgium. This ultimately led to the discovery of the previously unknown pathogen; the related Marburg virus had already been discovered in 1967, when researchers were seeking the cause of mysterious cases of illness in the German university town of Marburg.

With the isolation of the Ebola virus, named after a river, prevention and public-awareness measures could be introduced at the time. These ultimately made it possible to contain the first known Ebola epidemics in the Congo Basin and in Sudan. The largest and most severe outbreak to date began in 2014 in south-eastern Guinea, spread across several countries in West Africa and lasted until 2016. More than 28,000 people fell ill, and more than 11,000 of them died. A new vaccine helped to end that epidemic and subsequent ones, but doctors cannot currently rely on it: in mid-May 2026, the World Health Organization declared an epidemic in the DRC and Uganda a “public health emergency of international concern”. In this case, the Ebola pathogen is the rare Bundibugyo species — the vaccine must therefore be adapted accordingly.

For the Virchow Foundation, the work of the two prizewinners exemplifies cross-border and inclusive cooperation in global health. Across geographical, institutional and disciplinary boundaries, Piot and Muyembe have helped to improve understanding of epidemics and to combat them more effectively. Their work demonstrates the importance of international solidarity, shared responsibility and the inclusion of diverse perspectives in order to address health crises fairly and sustainably, according to a statement by the Virchow Foundation, whose five founders include the Berlin publisher Friede Springer and former Leopoldina President Gerald Haug.

Even after the discovery of the Ebola pathogen — five virus species are now distinguished — Piot remained committed to tackling global health crises. In the 1980s, he led research projects on HIV/AIDS in Africa and played a key role in the first major international HIV/AIDS project in a developing country: “SIDA” in Zaire. Among the important findings was the recognition that a mother can infect her child. The risk exists during pregnancy, at birth or through breastfeeding; today, transmission can be prevented through appropriate treatment.

Peter Piot’s commitment to multilateral cooperation and global health governance is also particularly noteworthy. As the founding Executive Director of UNAIDS, the Joint United Nations Programme on HIV/AIDS, he brought together UN organisations involved in the fight against AIDS. Under his leadership, UNAIDS became a central actor and advocate for global measures against HIV/AIDS.

Peter Piot obtained a doctorate in medicine from Ghent University and a doctorate in microbiology from the University of Antwerp. He worked, among other places, at the University of Nairobi and the Free University of Brussels, and was active for the World Health Organization (WHO). From 1995 to 2008, he headed the United Nations organisation UNAIDS and was also an Under-Secretary-General. Since 2010, he has been Professor of Global Health at the London School of Hygiene & Tropical Medicine, of which he was Director from 2010 to 2021. In 2018, he was admitted to the Leopoldina.

With the Virchow Prize, Piot, together with Muyembe, receives one of the world’s most highly endowed medical awards. In conferring the prize, the Virchow Foundation recognises exceptional achievements by outstanding individuals and organisations that make a lasting contribution to global health and support the Sustainable Development Goals of the United Nations’ 2030 Agenda. The prize was awarded for the first time in 2022; this year, the award ceremony will take place on 10 October at the Rotes Rathaus in Berlin.

The Leopoldina uses cookies

We use cookies on our website. Some of them are necessary (functional cookies), while others are not necessary but help us to improve our online offering and operate it economically.

You can consent to the use of non-essential cookies by clicking on the "Accept all" button or by clicking on individual settings and agreeing to them by clicking on "Accept selection".

You can access these settings at any time and deselect cookies at a later date.

Functional

These cookies are technically necessary in order to provide the following core functionalities of the website:

  • Display of the website
  • Anonymisation of IP addresses within log files
  • Status cookie consent
Comfort

In addition to necessary cookies, we also use cookies to make your use of the website more pleasant. If you accept these cookies, external media will be loaded without your further consent.

Tracking

With the help of statistics cookies, we can better customise the content and services of our website to your interests and needs. For statistics and analyses, we use the product Matomo for statistics and analyses.

External link warning

Die Nutzung dieses Teildienstes erfordert ihre Einwilligung in die Verarbeitung zusätzlicher personenbezogener Daten durch einen selbständigen Verantwortlichen: Matterport Inc., 352 E. Java Drive, Sunnyvale, CA 94089, USA. Es gelten folgende Datenschutzhinweise: https://matterport.com/de/node/44. Mit der Einwilligung durch Klick auf „Ok“ kann auch eine Übermittlung von personenbezogenen Daten in ein Land außerhalb der Europäischen Union erfolgen. Die Einwilligung ist freiwillig. Eine Ablehnung führt zu keinen Nachteilen. Eine erteilte Einwilligung kann jederzeit mit Wirkung für die Zukunft widerrufen werden.

Ich bin damit einverstanden, dass bei Nutzung dieses Teildienstes zusätzliche personenbezogene Daten verarbeitet werden. Dabei verarbeitete Datenkategorien: technische Verbindungsdaten des Serverzugriffs (IP-Adresse, Datum, Uhrzeit, abgefragte Seite, Browser-Informationen), Daten zur Erstellung von Nutzungsstatistiken und Daten über die Nutzung der Website sowie die Protokollierung von Klicks auf einzelne Elemente. Zweck der Verarbeitung: Auslieferung von Inhalten, die von Dritten bereitgestellt werden. Rechtsgrundlage für die Verarbeitung: Ihre Einwilligung nach Art. 6 (1) a DSGVO, Art. 49 DSGVO. Verantwortlicher für die Datenverarbeitung Matterport Inc., 352 E. Java Drive, Sunnyvale, CA 94089, USA. Es gilt die Datenschutzerklärung von Matterport Inc.: https://matterport.com/de/node/44.

Visit page ▸